Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.

scientific article

Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2174/0929867323666161227094049
P698PubMed publication ID28025938

P50authorIvan Beltran-HortelanoQ89347728
P2093author name stringSilvia Galiano
Silvia Perez-Silanes
P2860cites workDevelopment of a novel virtual screening cascade protocol to identify potential trypanothione reductase inhibitorsQ33419478
P433issue11
P921main subjectTrypanosoma cruziQ150162
Chagas diseaseQ649558
P304page(s)1066-1138
P577publication date2017-05-01
P1433published inCurrent Medicinal ChemistryQ3007710
P1476titleTrypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease
P478volume24

Reverse relations

cites work (P2860)
Q92774155Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity
Q61798291Oxidative Stress in Microbial Diseases: Pathogen, Host, and Therapeutics
Q98508491Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism
Q58865487Relevance of Trypanothione Reductase Inhibitors on Trypanosoma cruzi Infection: A Systematic Review, Meta-Analysis, and In Silico Integrated Approach

Search more.